FOXF2
Basic information
Region (hg38): 6:1389576-1395603
Previous symbols: [ "FKHL6" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FOXF2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 7 | |||||
missense | 25 | 28 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 5 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 25 | 11 | 5 |
Variants in FOXF2
This is a list of pathogenic ClinVar variants found in the FOXF2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-1389957-G-A | not specified | Uncertain significance (Sep 21, 2023) | ||
6-1389960-G-A | not specified | Uncertain significance (Feb 13, 2024) | ||
6-1389991-C-T | not specified | Uncertain significance (Aug 11, 2022) | ||
6-1389999-C-A | not specified | Uncertain significance (Apr 26, 2023) | ||
6-1390005-C-T | not specified | Uncertain significance (Mar 11, 2022) | ||
6-1390024-C-T | not specified | Uncertain significance (Dec 14, 2023) | ||
6-1390041-CCCG-C | FOXF2-related disorder | Benign (Aug 01, 2019) | ||
6-1390041-CCCGCCGCCG-C | FOXF2-related disorder | Likely benign (Feb 09, 2024) | ||
6-1390041-CCCGCCGCCGCCG-C | FOXF2-related disorder | Likely benign (Sep 01, 2022) | ||
6-1390041-C-CCCG | FOXF2-related disorder | Benign (Sep 20, 2019) | ||
6-1390068-G-T | FOXF2-related disorder | Likely benign (Feb 15, 2023) | ||
6-1390073-G-A | FOXF2-related disorder | Likely benign (Sep 25, 2023) | ||
6-1390074-G-C | not specified | Uncertain significance (Aug 14, 2023) | ||
6-1390143-G-A | not specified • FOXF2-related disorder | Uncertain significance (May 12, 2024) | ||
6-1390146-A-T | not specified | Uncertain significance (Aug 12, 2021) | ||
6-1390150-C-T | FOXF2-related disorder | Likely benign (Aug 01, 2019) | ||
6-1390178-C-T | FOXF2-related disorder | Likely benign (Apr 10, 2019) | ||
6-1390187-C-T | FOXF2-related disorder | Likely benign (Jan 04, 2024) | ||
6-1390207-G-A | not specified | Uncertain significance (Aug 12, 2021) | ||
6-1390207-G-T | not specified | Uncertain significance (Mar 15, 2024) | ||
6-1390299-A-T | not specified | Uncertain significance (Mar 30, 2024) | ||
6-1390300-G-C | not specified | Uncertain significance (Mar 30, 2024) | ||
6-1390322-G-A | FOXF2-related disorder | Likely benign (Sep 01, 2020) | ||
6-1390365-G-T | not specified | Uncertain significance (Mar 30, 2024) | ||
6-1390394-C-T | FOXF2-related disorder | Likely benign (May 22, 2020) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FOXF2 | protein_coding | protein_coding | ENST00000259806 | 2 | 5764 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.847 | 0.153 | 125735 | 0 | 13 | 125748 | 0.0000517 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.853 | 172 | 206 | 0.833 | 0.00000990 | 2807 |
Missense in Polyphen | 21 | 56.901 | 0.36906 | 587 | ||
Synonymous | -1.57 | 115 | 95.5 | 1.20 | 0.00000480 | 919 |
Loss of Function | 2.72 | 1 | 10.5 | 0.0949 | 4.52e-7 | 130 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000578 | 0.0000578 |
Ashkenazi Jewish | 0.0000993 | 0.0000992 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000998 | 0.0000924 |
European (Non-Finnish) | 0.0000713 | 0.0000703 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Probable transcription activator for a number of lung- specific genes.;
Haploinsufficiency Scores
- pHI
- 0.127
- hipred
- hipred_score
- ghis
- 0.401
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.909
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | High | Medium | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Foxf2
- Phenotype
- growth/size/body region phenotype; homeostasis/metabolism phenotype; vision/eye phenotype; craniofacial phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); skeleton phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype;
Zebrafish Information Network
- Gene name
- foxf2b
- Affected structure
- pericyte
- Phenotype tag
- abnormal
- Phenotype quality
- decreased occurrence
Gene ontology
- Biological process
- epithelial to mesenchymal transition;extracellular matrix organization;establishment of planar polarity of embryonic epithelium;negative regulation of transcription, DNA-templated;positive regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;embryonic digestive tract development;embryonic camera-type eye morphogenesis;genitalia development;roof of mouth development
- Cellular component
- nucleus;transcription factor complex
- Molecular function
- RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA binding;DNA-binding transcription factor activity;transcription factor binding;sequence-specific DNA binding